San Diego-based Aethlon Medical (OTCBB: [[ticker:AETH]]) said today it has begun the first clinical trial of a medical device to treat HIV. The device, called Aethlon Hemopurifier, filters viruses and immune-suppressing proteins, in order to help the immune system fight HIV. The trial, of six patients, is being conducted in India.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
